Machine learning-based survival modeling reveals distinct surgical benefits across molecular subtypes in young women with de novo metastatic breast cancer
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine-learning survival analyses in young women with de novo metastatic breast cancer identified molecular-subtype differences in observed surgical-benefit associations; this is retrospective treatment-effect modeling, not causal proof.
Technology: Machine-learning survival models stratified by breast-cancer molecular subtype
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Uses survival modeling stratified by molecular subtype to compare observed surgical-benefit associations in young women with de novo metastatic breast cancer.
- Test and result
- The retrospective survival analysis compares observed surgical-benefit associations across molecular subtypes in young women with de novo metastatic breast cancer; it does not establish causal benefit.
- Limitation / still unknown
- The subtype-specific treatment associations are retrospective and do not establish a causal benefit from surgery.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.21203/rs.3.rs-10816106/v1 · https://europepmc.org/article/PPR/PPR1331157 · https://www.researchsquare.com/article/rs-10816106/v1.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.